KC
ABBV icon

Kepos Capital’s AbbVie ABBV Stock Holding History

Kepos Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-38,052
Closed -$2.77M – 314
2019
Q2 		$2.77M Sell
38,052
-43,880
-54% -$3.45M 0.28% 66
2019
Q1 		$6.6M Buy
+81,932
New +$6.7M 0.5% 41
2018
Q4 		– Sell
-73,108
Closed -$6.92M – 335
2018
Q3 		$6.92M Buy
73,108
+2,078
+3% +$197K 0.35% 44
2018
Q2 		$6.58M Buy
71,030
+16,688
+31% +$1.63M 0.34% 46
2018
Q1 		$5.14M Buy
54,342
+5,017
+10% +$551K 0.3% 47
2017
Q4 		$4.77M Buy
+49,325
New +$4.65M 0.43% 32

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Kepos Capital's ABBV Position: Q3 2019 in Review

Kepos Capital sold out of AbbVie (ABBV) in Q3 2019, closing a stake of 38,052 shares — an estimated $2.77M sold.

Kepos Capital first reported a position in ABBV in Q4 2017 and held it in 6 quarters. The position peaked at $6.92M in Q3 2018. 2,002 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

  • Kepos Capital reported no remaining AbbVie position as of Q3 2019 after selling out during the quarter.
  • Kepos Capital sold 38,052 AbbVie shares in Q3 2019, an estimated $2.77M.
  • Kepos Capital first reported a position in AbbVie in Q4 2017 and held it in 6 quarters.
  • Kepos Capital's AbbVie position peaked at $6.92M in Q3 2018.
  • 2,002 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on Kepos Capital's 13F filing for Q3 2019, filed 13 Nov 2019.